Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Endoglin, VEGF, and its receptors in predicting metastases in endometrial carcinoma.

Saarelainen SK, Staff S, Peltonen N, Lehtimäki T, Isola J, Kujala PM, Vuento MH, Mäenpää JU.

Tumour Biol. 2014 May;35(5):4651-7. doi: 10.1007/s13277-014-1609-6. Epub 2014 Jan 14.

PMID:
24420153
2.

VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.

Fine BA, Valente PT, Feinstein GI, Dey T.

Gynecol Oncol. 2000 Jan;76(1):33-9.

PMID:
10620438
3.

Endoglin (CD105) expression in endometrial carcinoma.

Saad RS, Jasnosz KM, Tung MY, Silverman JF.

Int J Gynecol Pathol. 2003 Jul;22(3):248-53.

PMID:
12819391
4.

The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.

Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter KC, Harris AL, Koukourakis MI; Tumour and Angiogenesis Research Group.

Cancer. 2001 Nov 15;92(10):2569-77.

PMID:
11745191
5.

Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.

Saarelainen SK, Peltonen N, Lehtimäki T, Perheentupa A, Vuento MH, Mäenpää JU.

Am J Obstet Gynecol. 2013 Aug;209(2):142.e1-6. doi: 10.1016/j.ajog.2013.04.014. Epub 2013 Apr 10.

PMID:
23583212
6.

Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.

Ustuner Z, Saip P, Yasasever V, Vural B, Yazar A, Bal C, Ozturk B, Ozbek U, Topuz E.

Med Oncol. 2008;25(4):394-9. doi: 10.1007/s12032-008-9052-4. Epub 2008 Mar 4.

PMID:
18317954
7.

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS, Kim HJ, Kwon HC, Lee JH.

BMC Cancer. 2010 May 14;10:203. doi: 10.1186/1471-2407-10-203.

8.

CD105 expression is an independent predictor of survival in patients with endometrial cancer.

Erdem O, Taskiran C, Onan MA, Erdem M, Guner H, Ataoglu O.

Gynecol Oncol. 2006 Dec;103(3):1007-11. Epub 2006 Jul 18.

PMID:
16854456
9.

Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.

Dobrzycka B, Terlikowski SJ, Kwiatkowski M, Garbowicz M, Kinalski M, Chyczewski L.

Ginekol Pol. 2010 Jun;81(6):422-5.

PMID:
20695190
10.

[Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors].

Korzeniewska M, Kołomecki K, Stepień H, Naze M, Stepień T, Kuzdak K.

Endokrynol Pol. 2005 Jan-Feb;56(1):39-44. Polish.

PMID:
16335673
11.

Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.

Yu XM, Lo CY, Lam AK, Leung P, Luk JM.

Ann Surg. 2008 Mar;247(3):483-9. doi: 10.1097/SLA.0b013e31815fa447.

PMID:
18376194
12.

Combined perioperative plasma endoglin and VEGF--a assessment in colorectal cancer patients.

Myśliwiec P, Pawlak K, Kukliński A, Kedra B.

Folia Histochem Cytobiol. 2009;47(2):231-6. doi: 10.2478/v10042-009-0074-3.

13.

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study.

Poon RT, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, Fan ST, Wong J.

Ann Surg. 2001 Feb;233(2):227-35.

14.

Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.

Iwai K, Fukuda K, Hachisuga T, Mori M, Uchiyama M, Iwasaka T, Sugimori H.

Gynecol Oncol. 1999 Mar;72(3):351-9.

PMID:
10053107
15.

Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.

Govender N, Naicker T, Rajakumar A, Moodley J.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):100-5. doi: 10.1016/j.ejogrb.2013.05.021. Epub 2013 Jun 24.

PMID:
23806447
16.

Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.

Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF.

Mod Pathol. 2004 Feb;17(2):197-203.

17.

Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.

Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA.

APMIS. 2003 Nov;111(11):1011-8.

PMID:
14629267
18.

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.

Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.

Cancer. 1999 Jan 1;85(1):178-87.

PMID:
9921991
19.
20.

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK.

J Natl Cancer Inst. 1995 Apr 5;87(7):506-16.

PMID:
7707437
Items per page

Supplemental Content

Write to the Help Desk